E Nacheva
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 9
- Acute Myeloid Leukemia Research 4
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 14
- Genomic variations and chromosomal abnormalities 5
-
- Lymphoma Diagnosis and Treatment 7
- Oncology top 10%
- Viral-associated cancers and disorders 3
- Immunology top 10%
-
- Eosinophilic Disorders and Syndromes 3
-
- Acute Lymphoblastic Leukemia research 3
- Co-authors
- Martin J.S. DyerD JadayelC. GraceThomas BoehmA. FörsterIsabelle LavenirJonathan J. WatersRichard Baer
- Partner nations
- United KingdomAustraliaDenmark
In The Last Decade
E Nacheva
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 61
- Hematology 295
- Genetics 265
- Pathology and Forensic Medicine 233
- Oncology 325
- Immunology 234
Countries citing papers authored by E Nacheva
This map shows the geographic impact of E Nacheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Nacheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Nacheva more than expected).
Fields of papers citing papers by E Nacheva
This network shows the impact of papers produced by E Nacheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Nacheva. The network helps show where E Nacheva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E Nacheva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 17 | |
| 2 | 2014 | 37 | |
| 3 | 2013 | 42 | |
| 4 | 2008 | 27 | |
| 5 | 2007 | 0 | |
| 6 | 2003 | 10 | |
| 7 | 2003 | 4 | |
| 8 | 2001 | 11 | |
| 9 | 2000 | 5 | |
| 10 | 1998 | 7 | |
| 11 | Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. | 1997 | 85 |
| 12 | 1997 | 91 | |
| 13 | 1996 | 1 | |
| 14 | 1996 | 86 | |
| 15 | 1996 | 36 | |
| 16 | 1995 | 40 | |
| 17 | 1994 | 4 | |
| 18 | 1993 | 10 | |
| 19 | 1993 | 30 | |
| 20 | 1988 | 7 |
About E Nacheva
E Nacheva is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (9 papers), Lymphoma Diagnosis and Treatment (7 papers), Genomic variations and chromosomal abnormalities (5 papers), Acute Myeloid Leukemia Research (4 papers), Eosinophilic Disorders and Syndromes (3 papers), Viral-associated cancers and disorders (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Hematology (295 citations), Genetics (265 citations) and Pathology and Forensic Medicine (233 citations). E Nacheva has collaborated with scholars based in United Kingdom, Australia and Denmark. Frequent co-authors include Martin J.S. Dyer, D Jadayel, C. Grace, Thomas Boehm, A. Förster, Isabelle Lavenir, Jonathan J. Waters, Richard Baer, Terence H. Rabbitts and G Stranks. Their work appears in journals such as Blood, British Journal of Haematology, The EMBO Journal, Clinical Microbiology and Infection and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.